{"disease":{"id":"npc","name":"npc"},"drugs":{"marketed":[{"drug_id":"arimoclomol-citrate","indication_name":"Neurological manifestations of NPC","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ARIMOCLOMOL CITRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"toripalimab","indication_name":"metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loqtorzi","generic_name":"TORIPALIMAB","company_name":"Coherus Biosciences Inc","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"Programmed Death Receptor-1 Blocking Antibody [EPC]","quality_score":10,"revenue":null,"mechanism":"Loqtorzi blocks the PD-1 receptor, allowing the immune system to recognize and attack cancer cells."},{"drug_id":"toripalimab","indication_name":"recurrent unresectable or metastatic NPC","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loqtorzi","generic_name":"TORIPALIMAB","company_name":"Coherus Biosciences Inc","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"Programmed Death Receptor-1 Blocking Antibody [EPC]","quality_score":10,"revenue":null,"mechanism":"Loqtorzi blocks the PD-1 receptor, allowing the immune system to recognize and attack cancer cells."},{"drug_id":"arimoclomol","indication_name":"Niemann-Pick disease type C (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miplyffa","generic_name":"ARIMOCLOMOL","company_name":"Zevra Denmark","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":53,"revenue":null,"mechanism":"Miplyffa works by activating heat shock proteins to help protect cells from damage."},{"drug_id":"levacetylleucine","indication_name":"Niemann-Pick disease type C (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aqneursa","generic_name":"LEVACETYLLEUCINE","company_name":"Intrabio","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":46,"revenue":null,"mechanism":"Aqneursa works by modifying the activity of a specific enzyme involved in the breakdown of fatty substances in the body."}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06870435","title":"Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas","phase":"NA","overall_status":"RECRUITING","enrollment_count":68649,"lead_sponsor_name":"Ming-Yuan Chen","has_results":false},{"nct_id":"NCT07072143","title":"An International Study on Pediatric Patients With Rare Tumors.","phase":"","overall_status":"RECRUITING","enrollment_count":6250,"lead_sponsor_name":"Azienda Ospedaliera di Padova","has_results":false},{"nct_id":"NCT07013461","title":"International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"The University of Hong Kong-Shenzhen Hospital","has_results":false},{"nct_id":"NCT07088861","title":"Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1401,"lead_sponsor_name":"Lirong Wu","has_results":false},{"nct_id":"NCT03637634","title":"The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Hai-Qiang Mai,MD,PhD","has_results":false},{"nct_id":"NCT02586532","title":"Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China","phase":"","overall_status":"COMPLETED","enrollment_count":828,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07137052","title":"Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":732,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT06763289","title":"Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07201337","title":"Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06900218","title":"PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":664,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06749899","title":"QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":580,"lead_sponsor_name":"Sun Yat-Sen University Cancer Center","has_results":false},{"nct_id":"NCT07072000","title":"Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":550,"lead_sponsor_name":"Hai-Qiang Mai,MD,PhD","has_results":false},{"nct_id":"NCT07238569","title":"Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":516,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06829147","title":"A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07232680","title":"Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Cheng-En Hsieh","has_results":false},{"nct_id":"NCT06831357","title":"Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03919552","title":"Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":482,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06846450","title":"Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"Lin Kong, MD","has_results":false},{"nct_id":"NCT06712888","title":"Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":466,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07328841","title":"Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":456,"lead_sponsor_name":"Ming-Yuan Chen","has_results":false},{"nct_id":"NCT03973723","title":"Plasma EBV DNA Monitoring in Post-treatment NPC Patients","phase":"","overall_status":"COMPLETED","enrollment_count":441,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT07373990","title":"Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":418,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07385079","title":"Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":412,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06912698","title":"Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":342,"lead_sponsor_name":"Hai-Qiang Mai,MD,PhD","has_results":false},{"nct_id":"NCT06695936","title":"Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":329,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07340515","title":"Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Man Hu","has_results":false},{"nct_id":"NCT07042711","title":"Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT06708429","title":"Lynch Syndrome X-Talk of Enteral Mucosa With Immune System","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"San Raffaele University","has_results":false},{"nct_id":"NCT03581786","title":"The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":289,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":true},{"nct_id":"NCT07459296","title":"Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":266,"lead_sponsor_name":"First Affiliated Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT06612697","title":"Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":262,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT06770699","title":"Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":260,"lead_sponsor_name":"Jiangxi Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT07248670","title":"Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":252,"lead_sponsor_name":"Chongqing University Cancer Hospital","has_results":false},{"nct_id":"NCT07311772","title":"Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07362979","title":"Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":243,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06669611","title":"Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":242,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07303283","title":"Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":218,"lead_sponsor_name":"Kai Hu","has_results":false},{"nct_id":"NCT06763640","title":"Prognostic Value of TIL in Nasopharyngeal Carcinoma","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":216,"lead_sponsor_name":"Jiangxi Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT04215978","title":"Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"BeiGene","has_results":false},{"nct_id":"NCT07327216","title":"Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Affiliated Hospital of Guangdong Medical University","has_results":false},{"nct_id":"NCT07376603","title":"IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features","phase":"","overall_status":"RECRUITING","enrollment_count":169,"lead_sponsor_name":"Qiaojuan Guo","has_results":false},{"nct_id":"NCT07188584","title":"Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":166,"lead_sponsor_name":"Ming-Yuan Chen","has_results":false},{"nct_id":"NCT07085988","title":"Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":109,"lead_sponsor_name":"Jiangxi Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT07528183","title":"PD-1 Monoclonal Antibody Combined With Gemcitabine and Cisplatin Followed by Selective Radiotherapy for Unresectable Locally Recurrent NPC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":86,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06664983","title":"TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":84,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT00341575","title":"Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT06605131","title":"GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06839066","title":"A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Shanghai Henlius Biotech","has_results":false},{"nct_id":"NCT06987123","title":"TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07011329","title":"Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Hubei Cancer Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}